{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T12:50:00Z","timestamp":1685191800282},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,3,2]],"date-time":"2015-03-02T00:00:00Z","timestamp":1425254400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Egyptian National Cancer Institute"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.jnci.2015.02.004","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:19:00Z","timestamp":1426205940000},"page":"161-163","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long term survival with the combination of interferon and chemotherapy in metastatic melanoma"],"prefix":"10.1186","volume":"27","author":[{"given":"B\u00fclent","family":"Karag\u00f6z","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O\u011fuz","family":"Bilgi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpaslan","family":"\u00d6zg\u00fcn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Levent","family":"Emirzeo\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serkan","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet","family":"\u00d6zet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"36","key":"10.1016\/j.jnci.2015.02.004_b0005","doi-asserted-by":"crossref","first-page":"6199","DOI":"10.1200\/JCO.2009.23.4799","article-title":"Final version of 2009 AJCC melanoma staging and classification","volume":"27","author":"Balch","year":"2009","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jnci.2015.02.004_b0010","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1200\/JCO.1991.9.8.1403","article-title":"Improved results with the addition of interferon alfa-2b to dacarbazine in the treatment of patients with metastatic malignant melanoma","volume":"9","author":"Falkson","year":"1991","journal-title":"J Clin Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.jnci.2015.02.004_b0015","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2141.1991.tb08122.x","article-title":"Treatment of advanced malignant melanoma with recombinant interferon alfa-2a in combination with DTIC: long-term follow-up of two phase II studies","volume":"79","author":"Hersey","year":"1991","journal-title":"Br J Haematol"},{"issue":"35","key":"10.1016\/j.jnci.2015.02.004_b0020","doi-asserted-by":"crossref","first-page":"5748","DOI":"10.1200\/JCO.2008.17.5448","volume":"26","author":"Atkins","year":"2008","journal-title":"J Clin Oncol"},{"issue":"27","key":"10.1016\/j.jnci.2015.02.004_b0025","doi-asserted-by":"crossref","first-page":"6747","DOI":"10.1200\/JCO.2005.03.202","article-title":"Dacarbazine, cisplatin, and interferon-alfa-2b with or without interleukin-2 in metastatic melanoma: a randomized phase III trial (18951) of the European Organisation for Research and Treatment of Cancer Melanoma Group","volume":"23","author":"Keilholz","year":"2005","journal-title":"J Clin Oncol"},{"issue":"4","key":"10.1016\/j.jnci.2015.02.004_b0030","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S0889-8588(05)70025-3","article-title":"Adjuvant interferon treatment for melanoma","volume":"12","author":"Agarwala","year":"1998","journal-title":"Hematol Oncol Clin North Am"},{"issue":"5","key":"10.1016\/j.jnci.2015.02.004_b0035","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/1097-0142(19830301)51:5<840::AID-CNCR2820510516>3.0.CO;2-7","article-title":"LDH and melanoma","volume":"51","author":"Finck","year":"1983","journal-title":"Cancer"},{"issue":"7","key":"10.1016\/j.jnci.2015.02.004_b0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa053007","article-title":"Prognostic significance of autoimmunity during treatment of melanoma with interferon","volume":"354","author":"Gogas","year":"2006","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.jnci.2015.02.004_b0045","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/S1470-2045(11)70155-3","article-title":"Regulatory T cells in melanoma: the final hurdle towards effective immunotherapy?","volume":"13","author":"Jacobs","year":"2012","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.jnci.2015.02.004_b0050","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12032-008-9165-9","article-title":"CD8+CD28\u2212 cells and CD4+CD25+ regulatory T cells in the peripheral blood of advanced stage lung cancer patients","volume":"27","author":"Karagoz","year":"2010","journal-title":"Med Oncol"}],"container-title":["Journal of the Egyptian National Cancer Institute"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036215000102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1110036215000102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,21]],"date-time":"2019-08-21T23:21:06Z","timestamp":1566429666000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1110036215000102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S1110036215000102"],"URL":"https:\/\/doi.org\/10.1016\/j.jnci.2015.02.004","relation":{},"ISSN":["1110-0362"],"issn-type":[{"value":"1110-0362","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long term survival with the combination of interferon and chemotherapy in metastatic melanoma","name":"articletitle","label":"Article Title"},{"value":"Journal of the Egyptian National Cancer Institute","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jnci.2015.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}